Abstract
Sarah Moharem-Elgamal, Anna Baritussio, Ruxandra Christodorescu, Marc Ferrini, Giovanni Benfari, Filipa Xavier Valente, José F Rodríguez Palomares, Stefano Nistri
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
No local reference links have been materialized yet.
No local citing links have been materialized yet.
European cardiovascular magnetic resonance (EuroCMR) registry – multi national results from 57 centers in 15 countries
10.1186/1532-429x-15-9 · 2013
Cardiac magnetic resonance imaging using an open 0.35 T system
10.1097/01.rct.0000238010.64931.c6 · 2007
Improving cardiovascular magnetic resonance access in low- and middle-income countries for cardiomyopathy assessment: rapid cardiovascular magnetic resonance
10.1093/eurheartj/ehac035 · 2022
Unresolved referenced work
Kept as external metadata until matched
MRI-Derived Myocardial strain measures in normal subjects
10.1016/j.jcmg.2016.12.025 · 2018
Myocardial strain imaging: theory, current practice, and the future
10.1016/j.jcmg.2024.07.011 · 2025
Myocardial strain measurements derived from MR feature-tracking: influence of sex, age, field strength, and vendor
10.1016/j.jcmg.2023.05.019 · 2024
Allergic-like hypersensitivity reactions to gadolinium-based contrast agents: an 8-year cohort study of 154 539 patients
10.1148/radiol.210545 · 2022
Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review and meta-analysis
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1001/jamainternmed.2019.5284 · 2020
Contraindications to magnetic resonance imaging: non-invasive imaging
10.1136/hrt.2007.125039 · 2008
Nephrogenic systemic fibrosis in patients with advanced renal dysfunction following gadolinium-based contrast agents
10.1148/radiol.251794 · 2025
Use of intravenous gadolinium-based contrast Media in patients with kidney disease: consensus statements from the American college of radiology and the National Kidney Foundation
10.1148/radiol.2020202903 · 2021
Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve
10.1016/j.jacc.2007.04.053 · 2007
2023 ESC guidelines for the management of acute coronary syndromes
10.1093/eurheartj/ehad191 · 2023
The Canadian cardiovascular society classification of acute atherothrombotic myocardial infarction based on stages of tissue injury severity: an expert consensus statement
10.1016/j.cjca.2023.09.020 · 2024
The use of periinfarct contrast-enhanced cardiac magnetic resonance imaging for the prediction of late postmyocardial infarction ventricular dysfunction
10.1016/j.ahj.2008.04.012 · 2008
Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction
10.1161/circimaging.113.000702 · 2013
Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction
10.1016/j.jacc.2014.06.1194 · 2014
Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients
10.1016/j.jcmg.2014.05.010 · 2014
Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance
10.1016/j.jacc.2010.02.033 · 2010
Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study
10.1136/hrt.2007.122622 · 2008
Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine
10.1186/1745-6215-15-249 · 2014
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction
10.1056/nejm200011163432003 · 2000
Incidence, outcomes, and predictors of ventricular thrombus after reperfused ST-segment-elevation myocardial infarction by using sequential cardiac MR imaging
10.1148/radiol.2017161898 · 2017
Contrast-enhanced cardiovascular magnetic resonance imaging of right ventricular infarction
10.1016/j.jacc.2006.05.078 · 2006
Comparison of distinctive clinical and cardiac magnetic resonance features between ST elevation myocardial infarction patients with incomplete myocardial rupture and those with moderate to severe pericardial effusion
10.1177/2048872617719650 · 2019
Cardiovascular magnetic resonance of left ventricular pseudoaneurysm
10.1136/hrt.2004.039768 · 2005
True versus false left ventricular aneurysm: differentiation with MR imaging–initial experience
10.1148/radiol.2361031699 · 2005
Assessing patients with myocardial infarction and nonobstructed coronary arteries (MINOCA)
10.1111/j.1365-2796.2012.02591.x · 2013
2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
10.1093/eurheartj/ehaa575 · 2021
Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions
10.1093/eurheartj/ehz332 · 2019
Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA)
10.1093/ehjacc/zuab049 · 2021
How late is too late? Influence of CMR timing in suspected MINOCA
10.1093/eurheartj/ehaf784.2159 · 2025
Refining the role of CMR imaging in MINOCA
10.1016/j.jcmg.2021.03.024 · 2021
Early comprehensive cardiovascular magnetic resonance imaging in patients with myocardial infarction with nonobstructive coronary arteries
10.1016/j.jcmg.2021.02.021 · 2021
Myocardial infarction with nonobstructed coronary arteries: impact of CMR early after presentation
10.1016/j.jcmg.2016.11.010 · 2017
Early cardiac magnetic resonance imaging in troponin-positive acute chest pain and non-obstructed coronary arteries
10.1136/heartjnl-2019-316295 · 2020
Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries
10.1016/j.jcmg.2018.12.023 · 2019
Prognostic value of cardiac magnetic resonance imaging in acute coronary syndrome patients with troponin elevation and nonobstructive coronary arteries
10.1016/j.mayocp.2020.11.026 · 2021
2024 ESC guidelines for the management of chronic coronary syndromes
10.1093/eurheartj/ehae177 · 2024
2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy
10.1093/eurheartj/ehab364 · doi-reference
Joint British Society consensus recommendations for magnetic resonance imaging for patients with cardiac implantable electronic devices
10.1136/heartjnl-2022-320810 · doi-reference
Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices
10.1093/eurheartj/ehab350 · doi-reference
Making MRI available for patients with cardiac implantable electronic devices: growing need and barriers to change
10.1007/s00330-019-06449-5 · doi-reference
Access to MRI for patients with cardiac pacemakers and implantable cardioverter defibrillators
10.1136/openhrt-2021-001598 · doi-reference
British Heart Rhythm S. Safe use of MRI in people with cardiac implantable electronic devices
10.1136/heartjnl-2015-308495 · doi-reference
Cardiac masses, part 2: key imaging features for diagnosis and surgical planning
10.2214/ajr.11.6903 · doi-reference
MR imaging of cardiac tumors and masses: a review of methods and clinical applications
10.1148/radiol.13121239 · doi-reference
Value of CMR for the differential diagnosis of cardiac masses
10.1016/j.jcmg.2014.05.009 · doi-reference
Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis
10.1016/j.amjcard.2014.11.041 · doi-reference
Quantitative pericardial delayed hyperenhancement informs clinical course in recurrent pericarditis
10.1016/j.jcmg.2016.10.020 · doi-reference
Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study
10.1161/circulationaha.111.026070 · doi-reference
Magnetic resonance imaging of constrictive pericardial disease
10.1016/0002-9149(85)90398-4 · doi-reference
The functional right ventricle and tricuspid regurgitation in Ebstein's anomaly
10.1016/j.ijcard.2011.12.081 · doi-reference
Assessment of PDA shunt and systemic blood flow in newborns using cardiac MRI
10.1002/nbm.2927 · doi-reference
Arterial and venous blood flow: noninvasive quantitation with MR imaging
10.1148/radiology.185.3.1438767 · doi-reference
2020 ESC guidelines for the management of adult congenital heart disease
10.1093/eurheartj/ehaa554 · doi-reference
Sample size and cost analysis for pulmonary arterial hypertension drug trials using various imaging modalities to assess right ventricular size and function end points
10.1161/circimaging.113.000932 · doi-reference
Is MRI the preferred method for evaluating right ventricular size and function in patients with congenital heart disease? : MRI is the preferred method for evaluating right ventricular size and function in patients with congenital heart disease
10.1161/circimaging.113.000553 · doi-reference
2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical practice guidelines
10.1161/cir.0000000000001106 · doi-reference
False lumen flow assessment by magnetic resonance imaging and long-term outcomes in uncomplicated aortic dissection
10.1016/j.jacc.2022.04.017 · doi-reference
Implications of asymmetry and valvular morphotype on echocardiographic measurements of the aortic root in bicuspid aortic valve
10.1016/j.echo.2018.08.004 · doi-reference
Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement and corresponding normal values
10.1161/circimaging.108.768911 · doi-reference
Multimodality assessment of ascending aortic diameters: comparison of different measurement methods
10.1016/j.echo.2016.04.006 · doi-reference
Aortic dilatation and dissection in turner syndrome
10.1161/circulationaha.106.685487 · doi-reference
2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC)
10.1093/eurheartj/ehu281 · doi-reference
2024 ESC guidelines for the management of peripheral arterial and aortic diseases
10.1093/eurheartj/ehae179 · doi-reference
Aortic flow patterns and wall shear stress maps by 4D-flow cardiovascular magnetic resonance in the assessment of aortic dilatation in bicuspid aortic valve disease
10.1186/s12968-018-0451-1 · doi-reference
4D flow cardiovascular magnetic resonance consensus statement: 2023 update
10.1186/s12968-023-00942-z · doi-reference
False lumen rotational flow and aortic stiffness are associated with aortic growth rate in patients with chronic aortic dissection of the descending aorta: a 4D flow cardiovascular magnetic resonance study
10.1186/s12968-022-00852-6 · doi-reference
Wall shear stress predicts aortic dilation in patients with bicuspid aortic valve
10.1016/j.jcmg.2021.09.023 · doi-reference
Unenhanced MR angiography of the thoracic aorta: initial clinical evaluation
10.2214/ajr.07.2997 · doi-reference
Non-contrast-enhanced MR angiography of the thoracic aorta using cardiac and navigator-gated magnetization-prepared three-dimensional steady-state free precession
10.1002/jmri.21256 · doi-reference
Multimodality imaging of diseases of the thoracic aorta in adults: from the American Society of Echocardiography and the European Association of Cardiovascular Imaging: endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance
10.1016/j.echo.2014.11.015 · doi-reference
Detection of inflammatory aortopathies using multimodality imaging
10.1161/circimaging.118.008471 · doi-reference
CMR in inflammatory vasculitis
10.1186/1532-429x-14-82 · doi-reference
Usefulness of cardiac magnetic resonance imaging in aortic stenosis
10.1161/circimaging.119.010356 · doi-reference
Myocardial extracellular volume by T1 mapping: a new marker of arrhythmia in mitral valve prolapse
10.1186/s12968-021-00797-2 · doi-reference
T1 mapping and cardiac magnetic resonance feature tracking in mitral valve prolapse
10.1007/s00330-020-07140-w · doi-reference
Importance of myocardial fibrosis in functional mitral regurgitation: from outcomes to decision-making
10.1016/j.jcmg.2020.10.027 · doi-reference